EP3243526
Dreifing á RNA til að ræsa mörg ónæmisferli
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.7.2011EP published:
27.11.2019EP application number:
17177123.1
EP translation filed:
5.2.2020Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
5.7.2031Expiry date:
5.7.2026Next due date:
31.7.2026
Title:
DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS
Timeline
Today
6.7.2011EP application
27.11.2019EP Publication
5.2.2020Translation submitted
15.3.2020Registration published
5.7.2026Expires
Owner
Name:
GlaxoSmithKline Biologicals S.A.Address:
Rue de l'Institut, 89, 1330, Rixensart, BE
Inventor
Name:
GEALL, AndrewAddress:
Emeryville, CA, US
Name:
RAMSAUER, KatrinAddress:
Emeryville, CA, US
Name:
OTTEN, GillisAddress:
Emeryville, CA, US
Name:
MANDL, ChristianAddress:
Emeryville, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
361789 PDate:
6.7.2010Country:
US
Classification
Categories:
A61K 39/00, A61K 39/12
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 11.6.2020
Expires: 5.7.2021
Payer: Örn Þór slf.
Number: 11
Paid: 22.6.2021
Expires: 5.7.2022
Payer: Patice ehf.
Number: 12
Paid: 21.6.2022
Expires: 5.7.2023
Payer: Patice ehf.
Number: 13
Paid: 22.6.2023
Expires: 5.7.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 19.6.2024
Expires: 5.7.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.7.2025
Expires: 5.7.2026
Payer: Árnason Faktor ehf.